Therefore, we focused on n = 197 ccRCC patients with mutated VHL (mutVHL) and found that the 46 patients with the lowest expression levels of PFDN3 had the worst survival (p = 0.001, Fig 6B). This evidence concerns the gene VHL and nonpapillary renal cell carcinoma.